Senior insider sale
ASCENDIS PHARMA A/S — senior position signals high conviction
$62.3K
236.00 shares
What this filing means
HOLTUG LARS plans to sell 236.00 shares of ASCENDIS PHARMA A/S valued at approximately $62.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/2/2026ACC: 0001973379-26-000330
236.00
Shares to sell
$62.3K
Approx. market value
236.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
SHARE PLAN ACCOUNT
COMPENSATION
3/2/2026
236.00Total acquired236.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/2/2026 | SHARE PLAN ACCOUNT COMPENSATION | 236.00 | — |
| Total | 236.00 | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
236.00
Market value
$62.3K
9/2/2026
Total
Units
236.00
Value
$62.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/2/2026 | 236.00 | $62.3K | NASDAQ | Planned |
| Total | 236.00 | $62.3K | ||